Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Fricker

Showing results (121-130 of 193) with videos related to

Pageof 20
Sort By:
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Design, Synthesis, In Vitro and In Vivo Evaluation of Heterobivalent SiFA<i>lin</i>-Modified Peptidic Radioligands Targeting Both Integrin α<sub>v</sub>β<sub>3</sub> and the MC1 Receptor-Suitable for the Specific Visualization of Melanomas?Xia Cheng, Ralph Hübner, Valeska von Kiedrowski, et al.
Molecular Pharmaceutics|August 9, 2013
Dynamic regulation of P-glycoprotein in human brain capillariesJanine Avemary, Josephine D Salvamoser, Aurelia Peraud, et al.
Pharmaceutics|October 27, 2022
Toward Optimized <sup>89</sup>Zr-Immuno-PET: Side-by-Side Comparison of [<sup>89</sup>Zr]Zr-DFO-, [<sup>89</sup>Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [<sup>89</sup>Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?Helen Damerow, Xia Cheng, Valeska von Kiedrowski, et al.
Pharmaceuticals (Basel, Switzerland)|July 6, 2018
Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y₁)- and GRP-Receptors-An Improvement for Breast Cancer Imaging?Alicia Vall-Sagarra, Shanna Litau, Clemens Decristoforo, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 15, 2007
Transport of a fluorescent cAMP analog in teleost proximal tubulesValeska Reichel, Rosalinde Masereeuw, Jeroen J M W van den Heuvel, et al.
Colloids and Surfaces. B, Biointerfaces|May 1, 2016
Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatmentJoana A Loureiro, Bárbara Gomes, Gert Fricker, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 8, 2010
In situ formation of nanoparticles upon dispersion of melt extrudate formulations in aqueous medium assessed by asymmetrical flow field-flow fractionationJohanna Kanzer, Stefan Hupfeld, Terje Vasskog, et al.
Journal of Ethnopharmacology|June 15, 2014
Cytotoxicity and inhibition of P-glycoprotein by selected medicinal plants from ThailandChanai Noysang, Anne Mahringer, Maen Zeino, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 1, 2004
Lack of biliary lipid excretion in the little skate, Raja erinacea, indicates the absence of functional Mdr2, Abcg5, and Abcg8 transportersRonald P J Oude Elferink, Roelof Ottenhoff, Gert Fricker, et al.
Molecular Neurobiology|January 31, 2024
Increased Expression of Transferrin Receptor 1 in the Brain Cortex of 5xFAD Mouse Model of Alzheimer's Disease Is Associated with Activation of HIF-1 Signaling PathwaySabrina Petralla, Liudmila Saveleva, Katja M Kanninen, et al.
Pageof 20

Showing results (121-130 of 193) with videos related to

Sort By:
Pageof 20
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Design, Synthesis, In Vitro and In Vivo Evaluation of Heterobivalent SiFA<i>lin</i>-Modified Peptidic Radioligands Targeting Both Integrin α<sub>v</sub>β<sub>3</sub> and the MC1 Receptor-Suitable for the Specific Visualization of Melanomas?Xia Cheng, Ralph Hübner, Valeska von Kiedrowski, et al.
Molecular Pharmaceutics|August 9, 2013
Dynamic regulation of P-glycoprotein in human brain capillariesJanine Avemary, Josephine D Salvamoser, Aurelia Peraud, et al.
Pharmaceutics|October 27, 2022
Toward Optimized <sup>89</sup>Zr-Immuno-PET: Side-by-Side Comparison of [<sup>89</sup>Zr]Zr-DFO-, [<sup>89</sup>Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [<sup>89</sup>Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?Helen Damerow, Xia Cheng, Valeska von Kiedrowski, et al.
Pharmaceuticals (Basel, Switzerland)|July 6, 2018
Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y₁)- and GRP-Receptors-An Improvement for Breast Cancer Imaging?Alicia Vall-Sagarra, Shanna Litau, Clemens Decristoforo, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 15, 2007
Transport of a fluorescent cAMP analog in teleost proximal tubulesValeska Reichel, Rosalinde Masereeuw, Jeroen J M W van den Heuvel, et al.
Colloids and Surfaces. B, Biointerfaces|May 1, 2016
Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatmentJoana A Loureiro, Bárbara Gomes, Gert Fricker, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 8, 2010
In situ formation of nanoparticles upon dispersion of melt extrudate formulations in aqueous medium assessed by asymmetrical flow field-flow fractionationJohanna Kanzer, Stefan Hupfeld, Terje Vasskog, et al.
Journal of Ethnopharmacology|June 15, 2014
Cytotoxicity and inhibition of P-glycoprotein by selected medicinal plants from ThailandChanai Noysang, Anne Mahringer, Maen Zeino, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 1, 2004
Lack of biliary lipid excretion in the little skate, Raja erinacea, indicates the absence of functional Mdr2, Abcg5, and Abcg8 transportersRonald P J Oude Elferink, Roelof Ottenhoff, Gert Fricker, et al.
Molecular Neurobiology|January 31, 2024
Increased Expression of Transferrin Receptor 1 in the Brain Cortex of 5xFAD Mouse Model of Alzheimer's Disease Is Associated with Activation of HIF-1 Signaling PathwaySabrina Petralla, Liudmila Saveleva, Katja M Kanninen, et al.
Pageof 20